Blockade of A1 receptors by caffeine induces c-fos, zif-268 and ARC expression in the striatum through different interactions with the dopamine system.
Dassesse
D
D
Laboratory of Neurophysiology, Dept. Neuroscience, Université Libre de Bruxelles, Brussels, Belgium.
Vanderwinden
J M
JM
Golberg
I
I
Vanderhaeghen
J J
JJ
Schiffmann
S N
SN
D000818:Animals; D002110:Caffeine / Q000008:administration & dosage / Q000494:pharmacology*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D003598:Cytoskeletal Proteins / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D004298:Dopamine / Q000378:metabolism*; D051766:Early Growth Response Protein 1; D005786:Gene Expression Regulation / Q000187:drug effects*; D017781:Genes, Immediate-Early; D017874:Immediate-Early Proteins / Q000235:genetics*; D007267:Injections; D009419:Nerve Tissue Proteins / Q000235:genetics*; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics*; D058915:Purinergic P1 Receptor Antagonists; D051381:Rats; D014157:Transcription Factors / Q000235:genetics*
D000697:Central Nervous System Stimulants; D003598:Cytoskeletal Proteins; D004268:DNA-Binding Proteins; D051766:Early Growth Response Protein 1; C486110:Egr1 protein, rat; D017874:Immediate-Early Proteins; D009419:Nerve Tissue Proteins; D016760:Proto-Oncogene Proteins c-fos; D058915:Purinergic P1 Receptor Antagonists; D014157:Transcription Factors; C092069:activity regulated cytoskeletal-associated protein; D002110:Caffeine; D004298:Dopamine